Boundless Bio
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10955 Alexandria Way Ste 100, San Diego,...Phone Number
(858) 766-9912Website
www.boundlessbio.comRevenue
-Stock Symbol
BOLDIndustry
About Boundless Bio
Boundless Bio Org Chart
Is Boundless Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Boundless Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Boundless Bio launches new products
Check out if Boundless Bio is spiking on competitors!
Earning: See what the market has to say on Boundless Bio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Boundless Bio
Funding: Get notified immidiatlly once Boundless Bio has new funding data
Click to see if Boundless Bio had a recent Job posting/layoffs
Check if Boundless Bio has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Boundless Bio
Find more new buyers
Compare Similar Companies to Boundless Bio
Compare insights from companies similar to Boundless Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Boundless Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Boundless Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Boundless Bio.
Boundless Bio financials insights
Gather financial insights about Boundless Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$46.4M
Series B
$105M
Series C
$100M
Boundless Bio Tech Stack
A closer look at the technologies used by Boundless Bio
Most Recent Scoops
Boundless Bio News & Media
Boundless Bio to merge with Serapha in $230M deal | BOLD Stock News
Serapha’s lead base-editing program SERP-01 targets Alpha-1 Antitrypsin Deficiency. The combined company expects to trade as AATD on Nasdaq.Boundless Bio and Serapha Bio Announce Merger Agreement and - GlobeNewswire
Combined company to operate as Serapha Bio and to advance Serapha’s potential best-in-class in vivo base editing program for Alpha-1 Antitrypsin Deficiency...Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement
Combined company to operate as Serapha Bio and to advance Serapha’s potential best-in-class in vivo base editing program for Alpha-1 Antitrypsin DeficiencyBoundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Boundless Bio
Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with oncogene amplified cancers.... Read More